Company: CI
Filing Date: 2025-05-02
Form Type: 10-Q
Source: 0001739940-25-000021
Chunk: 43

Company: Cigna Group
Filing Date: 2025-05-02
Form: 10-Q
Item: Part I, Item 1
Chunk 43
---
 in discount rate for certain long-duration liabilities, before reclassification, net of tax benefit of $33 and $186, respectively(108)(546)Amounts reclassified to Shareholders' net income (loss), net of tax expense of $16 and $—, respectively(56)— Net current period change in discount rate for certain long-duration liabilities, net of tax benefit of  $49 and $186, respectively(164)(546)Net current period change in instrument-specific credit risk for market risk benefits, net of tax benefit of $1 and $4, respectively(4)(14)Other comprehensive (loss), net of tax(168)(560)Ending balance$(2,206)$(1,531)Translation of foreign currenciesBeginning balance$(198)$(149)Net translation of foreign currencies, before reclassification, net of tax (expense) of $(6) and $(2), respectively13 (26)Ending balance$(185)$(175)Postretirement benefits liabilityBeginning balance$(937)$(915)Amounts reclassified to Shareholders' net income, net of tax (benefit) of $(2) and $(3), respectively6 5 Ending balance$(931)$(910)Total Accumulated other comprehensive lossBeginning balance$(2,341)$(1,864)Shareholders' other comprehensive (loss), net of tax benefit of $82 and $141, respectively(249)(460)Ending balance$(2,590)$(2,324)

23

Note 14 – Strategic Optimization ProgramIn 2025, the Company commenced an enterprise-wide initiative to evolve our business and deliver a more efficient and improved experience for our patients, providers and customers. This program is expected to continue through December 2026 and include severance and other employee costs, accelerated asset amortization, and the operating results of certain small non-strategic businesses that we plan to discontinue. As we continue to evaluate additional opportunities to improve the overall efficiency and effectiveness of our operations, we anticipate future charges.During the three months ended March 31, 2025, we reported total costs of $215 million, pre-tax ($163 million, after-tax) associated with this initiative, including a charge in Selling, general and administrative expenses of $198 million, pre-tax ($150 million, after-tax) that was primarily associated with employee severance. The remainder reflects the operating results of certain non-strategic businesses. We expect substantially all of the accrued liability to be paid by the end of 2025.The following